Arpan Mohanty, MBBS

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Arpan Mohanty, MD, MSc is a hepatologist and clinical researcher at Boston Medical Center and Assistant Professor of Medicine Boston University Chobanian & Avedisian School of Medicine. Dr. Mohanty serves as the Director of Clinical Research in the Section of Gastroenterology
Dr. Mohanty’s research focuses on optimizing health-care delivery for advanced chronic liver disease and fatty liver disease. Her work has been supported by the National Institute on Minority Health and Health Disparities, the American Association for the Study of Liver Diseases, and the Radiological Society of North America, and she is the current recipient of the Robert Winn Career Development Award that focuses on community-oriented clinical trialists. She also serves as the principal investigator for several trials on chronic liver diseases. She is an active member of the American Association of Study of Liver Diseases and serves in its practice guidelines committee and fundamentals of liver disease committee.
Dr. Mohanty earned her medical degree in India, completed her internal medicine residency at the University of Pittsburgh Medical Center, gastroenterology fellowship at Yale New Haven Hospital, and advanced hepatology fellowship at Massachusetts General Hospital. She also holds a Master’s in Population Health from the Boston University School of Public Health. She is board certified in Internal Medicine, Gastroenterology, Transplant Hepatology and Obesity Medicine.

Publications

  • Published 6/26/2026

    Mohanty A, Stead AE, Telep LE, Singer AW, Curteis T, Zolotor A, Frenette C, Khoshabafard D, Hammond K, McQuaid T, Kelley RK. Hepatocellular carcinoma risk reduction associated with antiviral treatment in patients with noncirrhotic chronic hepatitis B: a systematic literature review and comparative meta-analysis. BMC Gastroenterol. 2026 Jun 26. PMID: 42363070.

    Read at: PubMed

  • Published 4/22/2026

    Sharpton S, Díaz LA, Pepin K, Amangurbanova M, Madamba E, Bettencourt R, Singh S, Valasek M, Dalupang M, Tesfai K, Middleton MS, Behling C, Dunn W, Nakajima A, Imajo K, Ogawa Y, Caussy C, Halegoua-DeMarzio D, Mohanty A, Huang DQ, Fuchs M, Hameed B, Stine JG, Balakrishnan M, Gray M, Rodriguez M, DeLeon A, Puskoor R, Vuppalanchi R, Behari J, Hansen L, Miller C, Medici V, Sarkar S, Boursier J, Tincopa M, Ajmera V, Richards L, Sirlin CB, Ehman RL, Loomba R. Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes. Aliment Pharmacol Ther. 2026 Apr 22. PMID: 42017265.

    Read at: PubMed

  • Published 4/17/2026

    Campos A, Liu T, Prescott B, Ma J, Haff MG, Walker ME, Mohanty A, Xanthakis V. Association of Life's Essential 8 with Hepatic Fibrosis, MASLD, and MetALD in the Framingham Heart Study. Nutrients. 2026 Apr 17; 18(8). PMID: 42075086.

    Read at: PubMed

  • Published 12/29/2025

    Austad K, Fantasia KL, Mohanty A, Jones KC, Bosch NA, Drainoni ML. Failing to succeed: advancing mechanistic understanding of implementation strategies through retrospective and prospective use of causal pathway diagrams. Implement Sci Commun. 2025 Dec 29; 7(1):35. PMID: 41462368.

    Read at: PubMed

  • Published 9/23/2025

    Austad K, Fantasia KL, Mohanty A, Jones KC, Bosch NA, Drainoni ML. Failing to Succeed: Advancing Mechanistic Understanding of Implementation Strategies Through Retrospective and Prospective Use of Causal Pathway Diagrams. Res Sq. 2025 Sep 23. PMID: 41041569.

    Read at: PubMed

View All 39 Publications:   View Full Profile in BUMC

Websites

Education

  • Rajiv Gandhi University of Health Sciences, MBBS

View all profiles